Morgan Keegan Initiates Solta Medical Coverage: Market Perform, $3.50 PT
Morgan Keegan initiated Solta Medical (NASDAQ: SLTM) coverage with a Market Perform rating and $3.50 price target in a research report published after the Tuesday market close.
In the report, Morgan Keegan states, "In our opinion, Solta has a sound business model that is predicated on a market segmentation strategy, cross seling, and generating a recurring revenue stream."
Shares of Solta Medical closed Tuesday at $2.82, down 2.08% from Monday's market close.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.